 Sharon Graw
Concepts (270)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cardiomyopathy, Dilated | 14 | 2022 | 352 | 1.460 |
Why?
| | Arrhythmogenic Right Ventricular Dysplasia | 6 | 2020 | 35 | 0.850 |
Why?
| | Arrhythmias, Cardiac | 7 | 2022 | 279 | 0.730 |
Why?
| | Cardiomyopathies | 4 | 2022 | 303 | 0.600 |
Why?
| | Filamins | 3 | 2021 | 19 | 0.520 |
Why?
| | Genes, BRCA1 | 2 | 2005 | 33 | 0.470 |
Why?
| | Electrocardiography | 5 | 2018 | 560 | 0.400 |
Why?
| | Connectin | 5 | 2022 | 30 | 0.350 |
Why?
| | Phenotype | 13 | 2022 | 2829 | 0.350 |
Why?
| | alpha7 Nicotinic Acetylcholine Receptor | 6 | 2016 | 96 | 0.340 |
Why?
| | Receptors, Nicotinic | 4 | 2012 | 273 | 0.320 |
Why?
| | Founder Effect | 2 | 2005 | 13 | 0.310 |
Why?
| | Genetic Predisposition to Disease | 7 | 2021 | 2125 | 0.300 |
Why?
| | Sequence Deletion | 3 | 2014 | 167 | 0.300 |
Why?
| | Mutation | 10 | 2020 | 3364 | 0.290 |
Why?
| | Myocardium | 5 | 2020 | 926 | 0.280 |
Why?
| | Heart Failure | 6 | 2022 | 1963 | 0.270 |
Why?
| | DNA Mutational Analysis | 7 | 2018 | 372 | 0.260 |
Why?
| | Genetic Variation | 4 | 2021 | 877 | 0.260 |
Why?
| | Jews | 1 | 2005 | 19 | 0.250 |
Why?
| | Death, Sudden, Cardiac | 4 | 2022 | 160 | 0.230 |
Why?
| | Mutation, Missense | 3 | 2015 | 296 | 0.230 |
Why?
| | Chromosomes, Human, Pair 8 | 2 | 2000 | 33 | 0.220 |
Why?
| | Breast Neoplasms | 2 | 2005 | 1872 | 0.210 |
Why?
| | Germ-Line Mutation | 1 | 2003 | 131 | 0.210 |
Why?
| | Cardiac Resynchronization Therapy | 1 | 2022 | 42 | 0.190 |
Why?
| | Glycogen Storage Disease Type IIb | 2 | 2014 | 22 | 0.190 |
Why?
| | Cardiomyopathy, Hypertrophic | 2 | 2016 | 120 | 0.180 |
Why?
| | Physical Chromosome Mapping | 1 | 2000 | 16 | 0.180 |
Why?
| | Chromosome Breakage | 1 | 2000 | 21 | 0.180 |
Why?
| | Cell Adhesion | 2 | 2018 | 433 | 0.180 |
Why?
| | Chromosome Inversion | 1 | 2000 | 17 | 0.180 |
Why?
| | Intellectual Disability | 1 | 2021 | 129 | 0.180 |
Why?
| | Muscle Proteins | 2 | 2012 | 209 | 0.170 |
Why?
| | Pedigree | 8 | 2015 | 467 | 0.170 |
Why?
| | Hippocampus | 2 | 2016 | 709 | 0.170 |
Why?
| | Ankyrins | 1 | 2019 | 7 | 0.170 |
Why?
| | Protein Kinases | 2 | 2012 | 306 | 0.170 |
Why?
| | Middle Aged | 19 | 2022 | 26999 | 0.170 |
Why?
| | Genotype | 5 | 2022 | 1786 | 0.160 |
Why?
| | Recombination, Genetic | 1 | 2000 | 177 | 0.160 |
Why?
| | Mice, Inbred C3H | 3 | 2016 | 244 | 0.160 |
Why?
| | Genetic Testing | 5 | 2020 | 382 | 0.160 |
Why?
| | Female | 31 | 2022 | 59913 | 0.160 |
Why?
| | Ovarian Neoplasms | 1 | 2003 | 407 | 0.160 |
Why?
| | Abnormalities, Multiple | 1 | 2000 | 176 | 0.160 |
Why?
| | Wnt Signaling Pathway | 1 | 2019 | 148 | 0.150 |
Why?
| | Disease Management | 3 | 2021 | 563 | 0.150 |
Why?
| | Transcriptome | 2 | 2020 | 736 | 0.150 |
Why?
| | Heart Ventricles | 3 | 2020 | 712 | 0.150 |
Why?
| | Humans | 39 | 2022 | 115587 | 0.140 |
Why?
| | Myocardial Ischemia | 1 | 2018 | 237 | 0.140 |
Why?
| | Isolated Noncompaction of the Ventricular Myocardium | 1 | 2016 | 3 | 0.140 |
Why?
| | Male | 27 | 2022 | 55949 | 0.140 |
Why?
| | Rho Guanine Nucleotide Exchange Factors | 1 | 2016 | 20 | 0.140 |
Why?
| | Internationality | 1 | 2017 | 145 | 0.140 |
Why?
| | Marfan Syndrome | 1 | 2017 | 41 | 0.140 |
Why?
| | Immunity, Cellular | 1 | 2018 | 262 | 0.140 |
Why?
| | Autism Spectrum Disorder | 1 | 2021 | 322 | 0.140 |
Why?
| | Adult | 18 | 2022 | 30718 | 0.140 |
Why?
| | Tumor Suppressor Protein p53 | 1 | 2020 | 449 | 0.130 |
Why?
| | RNA-Binding Proteins | 1 | 2019 | 362 | 0.130 |
Why?
| | Aortic Aneurysm, Thoracic | 1 | 2017 | 117 | 0.130 |
Why?
| | Long-Term Potentiation | 1 | 2016 | 145 | 0.120 |
Why?
| | Desmosomes | 1 | 2014 | 20 | 0.120 |
Why?
| | Spain | 2 | 2005 | 34 | 0.120 |
Why?
| | Receptors, Adrenergic | 1 | 2014 | 36 | 0.120 |
Why?
| | Receptors, Endothelin | 1 | 2014 | 49 | 0.120 |
Why?
| | Base Sequence | 5 | 2014 | 2114 | 0.120 |
Why?
| | Apoptosis Regulatory Proteins | 1 | 2014 | 174 | 0.110 |
Why?
| | Pharmacogenetics | 1 | 2014 | 151 | 0.110 |
Why?
| | Cardiovascular Agents | 1 | 2014 | 125 | 0.110 |
Why?
| | Prognosis | 4 | 2022 | 3339 | 0.100 |
Why?
| | Gene Expression Profiling | 1 | 2018 | 1536 | 0.100 |
Why?
| | Registries | 5 | 2021 | 1770 | 0.100 |
Why?
| | Colorado | 4 | 2017 | 4113 | 0.100 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2014 | 374 | 0.100 |
Why?
| | Genes, Duplicate | 1 | 2011 | 4 | 0.100 |
Why?
| | Schizophrenia | 3 | 2012 | 418 | 0.100 |
Why?
| | Neural Inhibition | 1 | 2012 | 152 | 0.090 |
Why?
| | Kaplan-Meier Estimate | 3 | 2017 | 815 | 0.080 |
Why?
| | Stroke Volume | 2 | 2022 | 509 | 0.080 |
Why?
| | Mice, Inbred C57BL | 2 | 2016 | 4773 | 0.080 |
Why?
| | Molecular Sequence Data | 5 | 2014 | 2790 | 0.080 |
Why?
| | Regulatory Sequences, Nucleic Acid | 1 | 2009 | 78 | 0.080 |
Why?
| | Ventricular Function, Left | 2 | 2022 | 467 | 0.080 |
Why?
| | Biomarkers | 1 | 2018 | 3466 | 0.080 |
Why?
| | DNA | 1 | 2014 | 1356 | 0.070 |
Why?
| | DNA Methylation | 1 | 2011 | 498 | 0.070 |
Why?
| | Promoter Regions, Genetic | 1 | 2011 | 1122 | 0.070 |
Why?
| | Desmin | 1 | 2007 | 30 | 0.070 |
Why?
| | Genetic Association Studies | 2 | 2021 | 343 | 0.070 |
Why?
| | Neurons | 1 | 2015 | 1298 | 0.070 |
Why?
| | Retrospective Studies | 5 | 2022 | 12608 | 0.070 |
Why?
| | Polymorphism, Single Nucleotide | 2 | 2018 | 1918 | 0.070 |
Why?
| | Cloning, Molecular | 3 | 2011 | 523 | 0.070 |
Why?
| | Echocardiography | 2 | 2021 | 558 | 0.070 |
Why?
| | Lamin Type A | 2 | 2022 | 40 | 0.070 |
Why?
| | Transcription, Genetic | 1 | 2011 | 1310 | 0.060 |
Why?
| | Mice, Knockout | 3 | 2019 | 2604 | 0.060 |
Why?
| | Syndrome | 2 | 2011 | 339 | 0.060 |
Why?
| | Ventricular Myosins | 1 | 2005 | 33 | 0.060 |
Why?
| | Cross-Sectional Studies | 3 | 2019 | 4435 | 0.060 |
Why?
| | Myosin Heavy Chains | 1 | 2005 | 169 | 0.060 |
Why?
| | Disease-Free Survival | 2 | 2015 | 621 | 0.060 |
Why?
| | Genes, BRCA2 | 1 | 2003 | 26 | 0.060 |
Why?
| | Exons | 2 | 2015 | 300 | 0.060 |
Why?
| | Haplotypes | 1 | 2005 | 457 | 0.060 |
Why?
| | Karyotyping | 2 | 2000 | 102 | 0.060 |
Why?
| | Brain | 1 | 2015 | 2370 | 0.060 |
Why?
| | DNA, Neoplasm | 1 | 2003 | 157 | 0.050 |
Why?
| | Chromosome Mapping | 5 | 2009 | 489 | 0.050 |
Why?
| | Animals | 10 | 2019 | 32102 | 0.050 |
Why?
| | Chromosomes, Human, Pair 15 | 2 | 2015 | 53 | 0.050 |
Why?
| | Cohort Studies | 3 | 2020 | 4944 | 0.050 |
Why?
| | Lysosomal-Associated Membrane Protein 2 | 2 | 2014 | 26 | 0.050 |
Why?
| | Microarray Analysis | 1 | 2021 | 119 | 0.050 |
Why?
| | Cell Line | 3 | 2009 | 2651 | 0.050 |
Why?
| | Time Factors | 3 | 2016 | 6165 | 0.050 |
Why?
| | Chromosomes | 1 | 2021 | 85 | 0.050 |
Why?
| | Chromosome Aberrations | 1 | 2021 | 134 | 0.050 |
Why?
| | Aged | 5 | 2022 | 19251 | 0.050 |
Why?
| | Case-Control Studies | 3 | 2018 | 3022 | 0.050 |
Why?
| | Heterozygote | 2 | 2015 | 252 | 0.050 |
Why?
| | Cricetinae | 2 | 2000 | 260 | 0.050 |
Why?
| | DNA Copy Number Variations | 1 | 2021 | 156 | 0.050 |
Why?
| | Gene Expression Regulation | 3 | 2020 | 2353 | 0.050 |
Why?
| | Terminal Repeat Sequences | 1 | 2000 | 14 | 0.040 |
Why?
| | Chromosome Deletion | 1 | 2000 | 95 | 0.040 |
Why?
| | New Mexico | 1 | 2000 | 59 | 0.040 |
Why?
| | Alu Elements | 1 | 2000 | 26 | 0.040 |
Why?
| | RNA, Messenger | 2 | 2020 | 2574 | 0.040 |
Why?
| | Long Interspersed Nucleotide Elements | 1 | 2000 | 25 | 0.040 |
Why?
| | Risk Assessment | 2 | 2019 | 2987 | 0.040 |
Why?
| | Membrane Proteins | 1 | 2005 | 1024 | 0.040 |
Why?
| | Maleimides | 1 | 2019 | 24 | 0.040 |
Why?
| | Risk Factors | 3 | 2019 | 8697 | 0.040 |
Why?
| | Principal Component Analysis | 1 | 2020 | 177 | 0.040 |
Why?
| | Transfection | 3 | 2011 | 866 | 0.040 |
Why?
| | Transforming Growth Factor beta1 | 1 | 2020 | 156 | 0.040 |
Why?
| | DNA-Binding Proteins | 1 | 2005 | 1316 | 0.040 |
Why?
| | Alleles | 1 | 2021 | 794 | 0.040 |
Why?
| | Academic Medical Centers | 1 | 2021 | 414 | 0.040 |
Why?
| | Cost-Benefit Analysis | 1 | 2021 | 548 | 0.040 |
Why?
| | Developmental Disabilities | 1 | 2021 | 240 | 0.040 |
Why?
| | Combined Modality Therapy | 1 | 2021 | 1127 | 0.040 |
Why?
| | Cluster Analysis | 1 | 2020 | 465 | 0.040 |
Why?
| | Family | 2 | 2014 | 594 | 0.040 |
Why?
| | Family Health | 2 | 2011 | 195 | 0.040 |
Why?
| | Collagen | 1 | 2020 | 415 | 0.040 |
Why?
| | Fibrosis | 1 | 2020 | 457 | 0.040 |
Why?
| | beta Catenin | 1 | 2019 | 220 | 0.040 |
Why?
| | HeLa Cells | 2 | 2011 | 567 | 0.040 |
Why?
| | Europe | 1 | 2018 | 336 | 0.040 |
Why?
| | Indoles | 1 | 2019 | 309 | 0.040 |
Why?
| | Mice | 4 | 2019 | 15052 | 0.030 |
Why?
| | Young Adult | 3 | 2017 | 10470 | 0.030 |
Why?
| | Aneurysm, False | 1 | 2017 | 46 | 0.030 |
Why?
| | Neck | 1 | 2017 | 84 | 0.030 |
Why?
| | Disease Models, Animal | 2 | 2019 | 3580 | 0.030 |
Why?
| | Head | 1 | 2017 | 86 | 0.030 |
Why?
| | Heredity | 1 | 2015 | 12 | 0.030 |
Why?
| | Sensory Gating | 1 | 2016 | 38 | 0.030 |
Why?
| | Computed Tomography Angiography | 1 | 2017 | 101 | 0.030 |
Why?
| | Adolescent | 5 | 2016 | 17889 | 0.030 |
Why?
| | Prevalence | 2 | 2015 | 2264 | 0.030 |
Why?
| | Italy | 1 | 2015 | 92 | 0.030 |
Why?
| | High-Throughput Nucleotide Sequencing | 1 | 2018 | 443 | 0.030 |
Why?
| | Electrocardiography, Ambulatory | 1 | 2015 | 54 | 0.030 |
Why?
| | Homozygote | 1 | 2015 | 186 | 0.030 |
Why?
| | Chromosomes, Artificial, Yeast | 1 | 1994 | 4 | 0.030 |
Why?
| | Species Specificity | 1 | 2016 | 552 | 0.030 |
Why?
| | Gene Duplication | 1 | 2015 | 62 | 0.030 |
Why?
| | Acoustic Stimulation | 1 | 2016 | 313 | 0.030 |
Why?
| | Cell Line, Tumor | 2 | 2011 | 2751 | 0.030 |
Why?
| | Genetic Linkage | 2 | 2011 | 297 | 0.030 |
Why?
| | Gene Frequency | 1 | 2015 | 485 | 0.030 |
Why?
| | Repetitive Sequences, Nucleic Acid | 1 | 1994 | 104 | 0.030 |
Why?
| | Polymerase Chain Reaction | 2 | 1994 | 1000 | 0.030 |
Why?
| | Chromosomes, Human, Pair 9 | 1 | 1993 | 43 | 0.030 |
Why?
| | Heart Defects, Congenital | 1 | 2000 | 659 | 0.030 |
Why?
| | United States | 3 | 2018 | 12295 | 0.030 |
Why?
| | Cause of Death | 1 | 2015 | 368 | 0.030 |
Why?
| | Immunohistochemistry | 1 | 2018 | 1642 | 0.030 |
Why?
| | Morbidity | 1 | 2014 | 278 | 0.030 |
Why?
| | Odds Ratio | 1 | 2016 | 962 | 0.030 |
Why?
| | Action Potentials | 1 | 2016 | 410 | 0.030 |
Why?
| | Heart | 1 | 2017 | 608 | 0.030 |
Why?
| | Age of Onset | 1 | 2014 | 450 | 0.030 |
Why?
| | Heart Rate | 1 | 2016 | 701 | 0.030 |
Why?
| | Infant, Newborn | 2 | 2000 | 5077 | 0.030 |
Why?
| | Multivariate Analysis | 1 | 2016 | 1440 | 0.030 |
Why?
| | Global Health | 1 | 2014 | 290 | 0.030 |
Why?
| | Genotyping Techniques | 1 | 2012 | 70 | 0.020 |
Why?
| | Mice, 129 Strain | 1 | 2012 | 77 | 0.020 |
Why?
| | Computational Biology | 1 | 2015 | 536 | 0.020 |
Why?
| | Penetrance | 1 | 2011 | 27 | 0.020 |
Why?
| | Bungarotoxins | 1 | 2011 | 44 | 0.020 |
Why?
| | Allosteric Regulation | 1 | 2011 | 84 | 0.020 |
Why?
| | Child | 3 | 2021 | 18488 | 0.020 |
Why?
| | Electrophysiological Phenomena | 1 | 2011 | 48 | 0.020 |
Why?
| | Predictive Value of Tests | 1 | 2016 | 1805 | 0.020 |
Why?
| | Primary Cell Culture | 1 | 2011 | 149 | 0.020 |
Why?
| | Isoxazoles | 1 | 2011 | 56 | 0.020 |
Why?
| | Logistic Models | 1 | 2016 | 1856 | 0.020 |
Why?
| | Organ Specificity | 1 | 2011 | 273 | 0.020 |
Why?
| | Xenopus laevis | 1 | 2011 | 118 | 0.020 |
Why?
| | Phenylurea Compounds | 1 | 2011 | 83 | 0.020 |
Why?
| | Multigene Family | 1 | 2011 | 193 | 0.020 |
Why?
| | Patch-Clamp Techniques | 1 | 2011 | 245 | 0.020 |
Why?
| | Point Mutation | 1 | 2011 | 217 | 0.020 |
Why?
| | Precision Medicine | 1 | 2014 | 344 | 0.020 |
Why?
| | Oocytes | 1 | 2011 | 171 | 0.020 |
Why?
| | Autistic Disorder | 1 | 2012 | 163 | 0.020 |
Why?
| | Child, Preschool | 2 | 2000 | 9133 | 0.020 |
Why?
| | Heart Transplantation | 1 | 2015 | 671 | 0.020 |
Why?
| | Ligands | 1 | 2011 | 569 | 0.020 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2011 | 930 | 0.020 |
Why?
| | Sequence Analysis, DNA | 1 | 2012 | 732 | 0.020 |
Why?
| | RNA | 2 | 2011 | 819 | 0.020 |
Why?
| | Disease Progression | 1 | 2015 | 2418 | 0.020 |
Why?
| | Linkage Disequilibrium | 1 | 2009 | 247 | 0.020 |
Why?
| | Treatment Outcome | 1 | 2022 | 9159 | 0.020 |
Why?
| | Severity of Illness Index | 1 | 2015 | 2578 | 0.020 |
Why?
| | Epilepsy | 1 | 2012 | 290 | 0.020 |
Why?
| | Cognition | 1 | 2015 | 980 | 0.020 |
Why?
| | Epigenesis, Genetic | 1 | 2011 | 526 | 0.020 |
Why?
| | Genetic Carrier Screening | 1 | 2007 | 24 | 0.020 |
Why?
| | Amino Acid Sequence | 1 | 2011 | 2000 | 0.020 |
Why?
| | Sex Characteristics | 1 | 2012 | 641 | 0.020 |
Why?
| | Genes, Dominant | 1 | 2007 | 93 | 0.020 |
Why?
| | Mental Disorders | 1 | 2015 | 902 | 0.020 |
Why?
| | Signal Transduction | 1 | 2020 | 4541 | 0.020 |
Why?
| | Prospective Studies | 1 | 2018 | 6264 | 0.020 |
Why?
| | Protein Binding | 1 | 2011 | 1917 | 0.020 |
Why?
| | Molecular Epidemiology | 1 | 2005 | 66 | 0.020 |
Why?
| | Microscopy, Fluorescence | 1 | 2007 | 402 | 0.020 |
Why?
| | Sarcomeres | 1 | 2005 | 89 | 0.020 |
Why?
| | Conserved Sequence | 1 | 2005 | 219 | 0.020 |
Why?
| | Protein Isoforms | 1 | 2005 | 339 | 0.010 |
Why?
| | Chromatography, Liquid | 1 | 2005 | 347 | 0.010 |
Why?
| | Smoking | 1 | 2011 | 1457 | 0.010 |
Why?
| | Protein Structure, Tertiary | 1 | 2005 | 804 | 0.010 |
Why?
| | DNA Primers | 2 | 1994 | 514 | 0.010 |
Why?
| | Myocytes, Cardiac | 1 | 2007 | 457 | 0.010 |
Why?
| | Genome-Wide Association Study | 1 | 2009 | 1217 | 0.010 |
Why?
| | Gene Expression | 1 | 2007 | 1435 | 0.010 |
Why?
| | Ventricular Dysfunction, Left | 1 | 2005 | 366 | 0.010 |
Why?
| | Cells, Cultured | 2 | 2007 | 3914 | 0.010 |
Why?
| | Chromosomes, Human, 21-22 and Y | 1 | 1981 | 4 | 0.010 |
Why?
| | Carbon-Nitrogen Ligases | 1 | 1981 | 4 | 0.010 |
Why?
| | Ligases | 1 | 1981 | 32 | 0.010 |
Why?
| | Rats | 1 | 2007 | 5034 | 0.010 |
Why?
| | Muscle, Skeletal | 1 | 2005 | 1447 | 0.010 |
Why?
| | Muridae | 1 | 1994 | 5 | 0.010 |
Why?
| | Electrophoresis, Gel, Pulsed-Field | 1 | 1994 | 17 | 0.010 |
Why?
| | Crosses, Genetic | 1 | 1994 | 141 | 0.010 |
Why?
| | Cosmids | 1 | 1993 | 6 | 0.010 |
Why?
| | Restriction Mapping | 1 | 1993 | 77 | 0.010 |
Why?
| | Infant | 1 | 2007 | 7979 | 0.010 |
Why?
| | Genetic Markers | 1 | 1994 | 325 | 0.010 |
Why?
| | Genome | 1 | 1994 | 271 | 0.010 |
Why?
| | Hybrid Cells | 1 | 1981 | 49 | 0.000 |
Why?
| | Genetic Complementation Test | 1 | 1981 | 61 | 0.000 |
Why?
| | Cell Fusion | 1 | 1981 | 50 | 0.000 |
Why?
| | Cricetulus | 1 | 1981 | 99 | 0.000 |
Why?
| | Purines | 1 | 1981 | 159 | 0.000 |
Why?
| | Ovary | 1 | 1981 | 190 | 0.000 |
Why?
| | Lymphocytes | 1 | 1981 | 344 | 0.000 |
Why?
| | Fibroblasts | 1 | 1981 | 839 | 0.000 |
Why?
|
|
Graw's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|